ScreenerHero
BHCBausch Health Companies Inc.
TSX · CA · Healthcare · Drug Manufacturers - Specialty & Generic · bauschhealth.com
9.320CAD-0.96%Mkt Cap: 2.56B $P/E: —

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The comp…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$65.19BUSDP/E 23.7
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$43.41BUSDP/E 20.1
ZOE
Zoetis Inc.
$29.89BUSDP/E 12.7
UTHR
United Therapeutics Corporation
$22.70BUSDP/E 19.0
VTRS
Viatris, Inc.
$18.66BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$15.34BUSDP/E 117.3
NBIX
Neurocrine Biosciences, Inc.
$15.81BUSDP/E 22.8
IPN
Ipsen S.A.
$14.67BUSDP/E 26.4
ELAN
Elanco Animal Health Incorporat
$12.24BUSD
KRK
Krka, d. d.
$8.66BUSDP/E 19.0
HIMS
Hims & Hers Health, Inc.
$7.25BUSD
LQDA
Liquidia Corporation
$6.74BUSDP/E 53.8
LNTH
Lantheus Holdings Inc
$6.56BUSDP/E 24.0
AMRX
Amneal Pharmaceuticals, Inc.
$6.23BUSDP/E 37.3
INDV
Indivior PLC Ordinary Shares
$4.61BUSDP/E 14.0
SFZN
Siegfried Holding AG
$4.01BUSDP/E 20.9
AMLX
Amylyx Pharmaceuticals Inc. Common Stock
$4.30BUSD
HIK
Hikma Pharmaceuticals PLC
$3.69BUSDP/E 12.7
ROVI
Laboratorios Farmaceuticos Rovi, S.A.
$3.32BUSDP/E 16.5
SUPN
Supernus Pharmaceuticals, Inc.
$2.82BUSD

Key Statistics

Company
Market Cap2.56B $
Enterprise Value17.07B $
Revenue (TTM)7.90B $
Gross Profit5.28B $
Net Income (TTM)114.34M $
Revenue/Share21.21 USD
Last Price9.320 CAD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees20.3K
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA0717341071
Valuation
P/E (Trailing)—
P/E (Forward)1.63
PEG0.02
EV/EBITDA6.00
EV/Revenue2.16
P/S0.32
P/B-1.44
EPS (TTM)-4.08
EPS (Forward)5.79
52W Range
6.10055% of range11.97
52W High11.97 CAD
52W Low6.100 CAD
Profitability
Gross Margin70.65%
Oper. Margin27.17%
EBITDA Margin36.01%
Profit Margin1.53%
ROE-28.34%
ROA0.60%
Growth
Revenue Growth12.70%
Earnings Growth70.40%
Cash Flow & Leverage
Operating CF1.02B $
CapEx (TTM)296.40M $
FCF Margin13.21%
FCF Yield40.74%
Net Debt13.80B $
Net Debt/EBITDA4.85
Balance Sheet
Debt/Equity-37.64
Current Ratio1.44
Quick Ratio0.90
Book Value/Sh-6.5425 CAD
Cash/Share4.880 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield6.46%
Payout Ratio0.00%
Ex-Div DateNov 10, 2010
Pay Date—
Splits
Last Split2:1
Split DateOct 5, 2000
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.373.99M
Float260.53M
Insiders11.12%
Institutions65.06%
Short Interest
Short Ratio5.9d
Short % Float1.23%
Short % Out.0.98%
Shares Short3.67M
Short (prev mo.)3.08M
Technical
SMA 507.448 (+25.1%)
SMA 2008.102 (+15.0%)
Beta0.38
S&P 52W Chg18.16%
Avg Vol (30d)682.92K
Avg Vol (10d)638.74K
Technical Indicators
RSI (14)68.3
MACD0.5798
MACD Signal0.4517
MACD Hist.+0.1281
BB Upper10.41 CAD
BB Middle7.931 CAD
BB Lower5.448 CAD
BB Width62.61%
ATR (14)0.4574 CAD
Vol Ratio (20d)0.48x